1-7 of 7
Janghee Woo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Preliminary Efficacy of DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study

Guillermo Garcia-Manero, Melissa Ooi, Zhentang Lao, Harinder Gill, Yasmin Abaza, Maximilian Stahl, Tamanna Haque, Amy E. DeZern, Peter L. Greenberg, Marc Pelletier, Arti Singh, Daniel Carreon, Valerie Beaulieu, Janghee Woo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3250.
https://doi.org/10.1182/blood-2023-174642
Published: 2023
Journal Articles

Activation of Distinct Inflammatory Pathways in LR-MDS Is Determined By Genetics

Marie Schneider, Clara Rolfs, Matthias Trumpp, Susann Winter, Luise Fischer, Mandy Richter, Victoria Menger, Kolja Nenoff, Nora Grieb, Anne Sophie Kubasch, Klaus H. Metzeler, Katja Sockel, Christian Thiede, Lorenz C Hofbauer, Andreas Roth, Andreas Bruederle, Janghee Woo, Michael Cross, Uwe Platzbecker
Journal: Blood
Blood (2022) 140 (Supplement 1): 4011–4012.
https://doi.org/10.1182/blood-2022-163246
Published: 2022
Journal Articles

Canakinumab Effects on Erythropoiesis, Cardiovascular Risk, and Clonal Hematopoiesis: Proteogenomic Analysis of the Cantos Randomized Clinical Trial

Janghee Woo, Darlene Lu, Andrew Lewandowski, Paul M. Ridker, Benjamin L. Ebert, David Steensma
Journal: Blood
Blood (2022) 140 (Supplement 1): 2236–2237.
https://doi.org/10.1182/blood-2022-167275
Published: 2022
Journal Articles

Investigating the Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) on Ibrutinib Therapy: Results from a Phase Ib Study

Kerry A. Rogers, Ian W. Flinn, Deborah M. Stephens, Thomas J. Kipps, Sarah Larson, Carolyn McGarry, Nadia B. Hassounah, Liangke Connie Gou, Janghee Woo, John C. Byrd
Journal: Blood
Blood (2021) 138 (Supplement 1): 2631.
https://doi.org/10.1182/blood-2021-147775
Published: 2021
Journal Articles

Real-World Evaluation of the Treatment Landscape for Chronic Lymphocytic Leukemia

Timothy W. Smith, Henry F. Owusu, David Wormser, Janghee Woo
Journal: Blood
Blood (2021) 138 (Supplement 1): 1559.
https://doi.org/10.1182/blood-2021-147885
Published: 2021
Journal Articles

Phase Ib Study of Ianalumab (VAY736) and Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) on Ibrutinib Therapy

Kerry A. Rogers, MD, Ian W. Flinn, MD PhD, Carolyn McGarry, PhD, Liangke Connie Gou, PhD, Nadia Hassounah, PhD, Janghee Woo, MD, John C. Byrd, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-137629
Published: 2020
Journal Articles

Regulatory Reprogramming of Erythropoiesis By DNMT3A Mutation

Janghee Woo, MDPhD, Sandra Stehling-Sun, PhD, H. Joachim Deeg, MD, Thalia Papayannopoulou, MD DrSci, Fyodor D Urnov, PhD, John A Stamatoyannopoulos, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4343.
https://doi.org/10.1182/blood-2018-99-120110
Published: 2018